|
Head & Neck TNM Staging: T = Tumor, N = Nodal Status, M = Metastasis
|
Site/Type |
Protocol Title |
| Resectable |
None |
| Oropharyngeal-Advanced squamous cell |
None |
Pathological Stage III/IV
Preoperative clinical stage may be I-IV and meet specific creiteria |
RTOG 0522: Intense Modulated Radiation Therapy (IMRT) plus Cisplatin followed by Surgery versus Imtense Modulated Radiation Therapy (IMRT) plus Cisplatin and Cetuximab followed by Surgery
RTOG 619: Cisplatin plus concurrent radiation therapy versus Cisplatin plus Vandetanib with concurrent radiation therapy |
| Nasopharyngeal-locally or regionally advanced |
RTOG 0615: Cisplatin and Bevacizumab plus concurent radiation therapy versus Cisplatin, continuous infusion 5FU and Bevacizumab plus concurent radiation therapy
|
| Recurrent/Metastatic |
ECOG E1305: Cisplatin or Carboplatin, 5FU, Docetaxel with or without Bevacizumab
Schering Plough P04273: Temozolomide for CA selected for methylation of O6 methyl-guanine DNA Methyl-transferase promoter--May have received one prior treatment |
Lorhan Registry: Prospective, longitudinal, multi-center descriptive registry of patients receiving therapy for Head and Neck Cancers
|
Breast Cancer Clinic
